MERLINO, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 775
EU - Europa 658
AS - Asia 164
AF - Africa 22
SA - Sud America 7
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.629
Nazione #
US - Stati Uniti d'America 765
IT - Italia 446
CN - Cina 100
NL - Olanda 78
VN - Vietnam 40
IE - Irlanda 38
FI - Finlandia 22
GB - Regno Unito 21
CI - Costa d'Avorio 20
DE - Germania 20
CA - Canada 10
FR - Francia 9
IN - India 9
SE - Svezia 6
BG - Bulgaria 5
SG - Singapore 5
BR - Brasile 4
PL - Polonia 4
HK - Hong Kong 3
RO - Romania 3
AU - Australia 2
ES - Italia 2
JP - Giappone 2
MA - Marocco 2
TR - Turchia 2
AR - Argentina 1
BD - Bangladesh 1
BY - Bielorussia 1
CL - Cile 1
EU - Europa 1
GR - Grecia 1
KR - Corea 1
MK - Macedonia 1
PH - Filippine 1
PT - Portogallo 1
PY - Paraguay 1
Totale 1.629
Città #
Chandler 208
Naples 84
Amsterdam 72
Napoli 66
Ashburn 59
Millbury 46
Dong Ket 40
Beijing 38
Des Moines 31
Nanjing 25
Princeton 20
Lawrence 19
Boston 17
Milan 16
Dublin 12
Rome 12
Viterbo 9
Arce 8
Lappeenranta 8
Nanchang 8
Wilmington 8
Florence 7
Ottawa 7
Pescopagano 7
Salerno 7
Fairfield 6
Seattle 6
Shenyang 6
Caserta 5
Los Angeles 5
Pune 5
Redwood City 5
Sofia 5
Trieste 5
Acerra 4
Acton 4
Cachan 4
Como 4
Dresden 4
Naaldwijk 4
Augusta 3
Changsha 3
Dearborn 3
Gdansk 3
Hebei 3
Hong Kong 3
Kronberg 3
London 3
Mercato San Severino 3
Norwalk 3
Piombino 3
Pisa 3
Tianjin 3
Villeurbanne 3
Woodbridge 3
Wuhan 3
Albenga 2
Avellino 2
Bacoli 2
Cambridge 2
Camerino 2
Chieti 2
Cisterna di Latina 2
Coventry 2
Formia 2
Guangzhou 2
Lauria 2
Marano di Napoli 2
Montale 2
New York 2
Ningbo 2
Pellezzano 2
Pisticci 2
Pomezia 2
Portici 2
Recife 2
Regalbuto 2
Vedelago 2
Agropoli 1
Altamura 1
Amalfi 1
Angeles City 1
Ann Arbor 1
Anzio 1
Aquila 1
Asunción 1
Aversa 1
Barano D'ischia 1
Bari 1
Battipaglia 1
Bergamo 1
Boardman 1
Bologna 1
Caivano 1
Calvizzano 1
Campinas 1
Campora 1
Casablanca 1
Castellammare di Stabia 1
Centro 1
Totale 1.020
Nome #
1H NMR-based metabolomics study on follicular fluid from patients with Polycystic Ovary Syndrome 101
Antimicrobial peptide Temporin-L complexed with anionic cyclodextrins results in a potent and safe agent against sessile bacteria 78
Functional Selectivity Revealed by N-Methylation Scanning of Human Urotensin II and Related Peptides 71
Urokinase receptor derived peptides as potent inhibitors of the formyl peptide receptor type 1-triggered cell migration 57
Intestinal anti-inflammatory effect of a peptide derived from gastrointestinal digestion of buffalo (Bubalus bubalis) mozzarella cheese 57
Cyclization of the urokinase receptor-derived Ser-Arg-Ser-Arg-Tyr peptide generates a potent inhibitor of trans-endothelial migration of monocytes 53
Urotensin-II Receptor: A Double Identity Receptor Involved in Vasoconstriction and in the Development of Digestive Tract Cancers and other Tumors 52
From a Helix to a Small Cycle: Metadynamics-Inspired αvβ6 Integrin Selective Ligands 47
Glycine-replaced derivatives of [Pro3,DLeu9]TL, a temporin L analogue: Evaluation of antimicrobial, cytotoxic and hemolytic activities 46
An investigation into the origin of the biased agonism associated with the urotensin II receptor activation 43
Urotensin II(4-11) Azasulfuryl Peptides: Synthesis and Biological Activity 43
Disulfide bond replacement with 1,4‐ and 1,5‐disubstituted [1,2,3]‐triazole on C‐X‐C chemokine receptor type 4 (CXCR4) peptide ligands: small changes that make big differences 43
Microwave-Assisted Synthesis of 2-Methyl-1H-indole-3-carboxylate Derivatives via Pd-Catalyzed Heterocyclization 42
Novel temporin L antimicrobial peptides: promoting self-assembling by lipidic tags to tackle superbugs 42
Discovery of New Potent Ligands at Human Urotensin-II Receptor 41
Synthesis and Pharmacological Evaluation of a Novel Peptide Based on Anemonia sulcata BDS-I Toxin as a New KV3.4 Inhibitor Exerting a Neuroprotective Effect Against Amyloid-β Peptide 40
Unveiling the mechanism of action of acylated temporin L analogues against multidrug-resistant Candida albicans 39
Temporin L-derived peptide as a regulator of the acute inflammatory response in zymosan-induced peritonitis 39
Novel Antimicrobial Peptide from Temporin L in The Treatment of Staphylococcus pseudintermedius and Malassezia pachydermatis in Polymicrobial Inter-Kingdom Infection 38
Novel α-MSH peptide analogues with broad spectrum antimicrobial activity. 37
Boosting Fmoc Solid-Phase Peptide Synthesis by Ultrasonication 36
null 35
Antimicrobial Activity of a Lipidated Temporin L Analogue against Carbapenemase-Producing Klebsiella pneumoniae Clinical Isolates 35
Discovery of Novel Potent and Selective Agonists at the Melanocortin-3 Receptor 34
Structure-Activity Study of the Peptides P5U and Urantide by the Development of Analogues Containing Uncoded Amino Acids at Position9 32
Activation of Melanocortin Receptors MC1 and MC5 Attenuates Retinal Damage in Experimental Diabetic Retinopathy 32
Breast tumor cell invasion and pro-invasive activity of cancer-associated fibroblasts co-targeted by novel urokinase-derived decapeptides 32
HOPPI-NMR: Hot-Peptide-Based Screening Assay for Inhibitors of Protein-Protein Interactions by NMR 31
Treatment with a Urokinase Receptor-derived Cyclized Peptide Improves Experimental Colitis by Preventing Monocyte Recruitment and Macrophage Polarization 30
The Outcomes of Decorated Prolines in the Discovery of Antimicrobial Peptides from Temporin-L 30
Urotensin II receptor expression in patients with ulcerative colitis: a pilot study 30
Urotensin-II-Targeted Liposomes as a New Drug Delivery System towards Prostate and Colon Cancer Cells 30
First-in-Class Cyclic Temporin L Analogue: Design, Synthesis, and Antimicrobial Assessment 30
Broad-Spectrum Antiviral Activity of the Amphibian Antimicrobial Peptide Temporin L and Its Analogs 28
DESIGN AND SYNTHESIS OF N-METHYL DERIVATIVES OF UROTENSIN-II 28
Development of Macrocyclic Peptidomimetics Containing Constrained α,α-Dialkylated Amino Acids with Potent and Selective Activity at Human Melanocortin Receptors 28
HOST DEFENSE TEMPORIN 1 PEPTIDES AND THEIR POTENTIAL AS ANTIVIRAL AGENTS 26
Synthesis of temporin L hydroxamate-based peptides and evaluation of their coordination properties with iron (III) 25
New insight into the binding mode of peptides at urotensin-II receptor by Trp-constrained analogues of P5U and urantide. 23
Lead Optimization of P5U and Urantide: Discovery of Novel Potent Ligands at the Urotensin-II Receptor 23
Antifungal and Antibiofilm Activity of Cyclic Temporin L Peptide Analogues against Albicans and Non-Albicans Candida Species 22
Urotensin-II Ligands: An Overview from Peptide to Nonpeptide Structures 22
Simultaneous Targeting of RGD-Integrins and Dual Murine Double Minute Proteins in Glioblastoma Multiforme 21
Novel anti-inflammatory and chondroprotective effects of the human melanocortin MC1 receptor agonist BMS-470539 dihydrochloride and human melanocortin MC3 receptor agonist PG-990 on lipopolysaccharide activated chondrocytes 19
Ad-hoc modifications of cyclic mimetics of SOCS1 protein: Structural and functional insights 15
Unveiling the interaction between DNA G-quadruplexes and RG-rich peptides 15
A Small CEACAM5 Peptide Restores the Protective Function of CD8+ Regulatory T Cells in Crohn's Disease 13
CheckMate 141 trial: all that glitters is not gold 13
The urotensin-II receptor: A marker for staging and steroid outcome prediction in ulcerative colitis 12
SIRT6 interacts with TRF2 and promotes its degradation in response to DNA damage 9
Synthetic Amphipathic β-Sheet Temporin-Derived Peptide with Dual Antibacterial and Anti-Inflammatory Activities 8
New biologic (Ab-IPL-IL-17) for IL-17-mediated diseases: identification of the bioactive sequence (nIL-17) for IL-17A/F function 7
PEPTIDE AD ATTIVITÀ ANTIMICOTICA E ANTIBATTERICA 5
Ultrasound-assisted Peptide Nucleic Acids synthesis (US-PNAS) 3
Totale 1.791
Categoria #
all - tutte 6.353
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.353


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201911 0 0 0 0 0 0 0 0 0 4 5 2
2019/2020184 49 5 12 21 13 9 8 9 2 22 26 8
2020/2021210 16 1 12 4 25 44 6 16 16 13 12 45
2021/2022306 7 3 13 7 20 4 6 13 39 41 54 99
2022/2023578 44 32 27 43 74 72 12 62 95 75 29 13
2023/2024339 18 66 45 27 39 39 17 62 9 17 0 0
Totale 1.791